3SBio (STU:83B) ROE % Adjusted to Book Value: 32.30% (As of Dec. 2025)

3SBio STU:83B +7.34% 85 ROE % Adjusted to Book Value is 32.30% as of Dec. 2025. GuruFocus rates STU:83B with a GF Score™ of 85/100 and a GF Value™ of €1.39 (Significantly Overvalued). The stock has 1 warning sign investors should review.

3SBio's ROE % for the quarter that ended in Dec. 2025 was 65.57%. 3SBio's PB Ratio for the quarter that ended in Dec. 2025 was 2.03. 3SBio's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 32.30%.

3SBio ROE % Adjusted to Book Value Related Terms

3SBio ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for 3SBio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio ROE % Adjusted to Book Value Chart

3SBio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

14.64

11.22

9.91

16.86

19.03

3SBio Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															7.29	16.13	15.96	5.53	32.30

STU:83B vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, 3SBio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where 3SBio's ROE % Adjusted to Book Value falls into.

Save Embed

85GF Score

3SBio Inc STU:83B

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

3SBio ROE % Adjusted to Book Value Calculation

3SBio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	38.64%	/	2.03
	=	19.03%

3SBio's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	65.57%	/	2.03
	=	32.30%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 32.30% mean?

3SBio (STU:83B) has a ROE % Adjusted to Book Value of 32.30% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on 3SBio and its competitors.

Is 3SBio's ROE % Adjusted to Book Value too high?

3SBio's current ROE % Adjusted to Book Value is 32.30%. Overall, 3SBio has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does 3SBio's ROE % Adjusted to Book Value compare to VRTX and REGN?

3SBio's ROE % Adjusted to Book Value of 32.30% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Biotechnology company?

A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on 3SBio and its competitors. 3SBio's current ROE % Adjusted to Book Value is 32.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is 3SBio stock overvalued right now?

Based on GuruFocus' analysis, 3SBio (STU:83B) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.39, compared to a current price of €1.97 — trading 41.6% above its estimated fair value. The current ROE % Adjusted to Book Value is 32.30%. 3SBio's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For 3SBio (STU:83B), the current ROE % Adjusted to Book Value is 32.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3SBio (STU:83B) Overvalued in 2026?

Based on GuruFocus' analysis, 3SBio stock appears to be overvalued. The current stock price of €1.97 is trading 41.6% above its estimated GF Value™ of €1.39. GuruFocus considers 3SBio to be Significantly Overvalued.

Key valuation signals for STU:83B:

ROE % Adjusted to Book Value: 32.30%
GF Value™: €1.39 vs. price of €1.97 (41.6% above fair value)
GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the STU:83B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3SBio Business Description

Industry Healthcare Biotechnology

Comparable Companies HKSE:01877 HKSE:02315 HKSE:02696 HKSE:01548 HKSE:09969 HKSE:02162 HKSE:09606 HKSE:07666 HKSE:06872 HKSE:06855 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges TRSBF:USA 01530:Hong Kong

Address No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN

Website https://www.3sbio.com

3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.

85GF Score

Get the complete analysis for STU:83B

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.97

Price

€1.39

GF Value

View STU:83B Analysis

See ROE % Adjusted to Book Value data for all stocks →